Clinical Trial Update: Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating ACT-451840 for early blood-stage Plasmodium falciparum infection in healthy subjects completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• ACT-451840

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Healthy Subjects | Phase 1 | Status: COMPLETED | Results posted: 2016-08-10